PAIN THERAPEUTICS INC's ticker is PTIE and the CUSIP is 69562K100. A total of 69 filers reported holding PAIN THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $142,000 | -11.2% | 159,479 | -43.0% | 0.00% | – |
Q4 2016 | $160,000 | -51.7% | 279,592 | -15.5% | 0.00% | -100.0% |
Q3 2016 | $331,000 | -60.1% | 331,072 | -12.6% | 0.00% | -50.0% |
Q2 2016 | $829,000 | -5.7% | 378,601 | -3.9% | 0.00% | 0.0% |
Q1 2016 | $879,000 | +27.8% | 393,945 | +0.3% | 0.00% | +100.0% |
Q4 2015 | $688,000 | -4.3% | 392,845 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $719,000 | +2.6% | 392,845 | -3.0% | 0.00% | 0.0% |
Q2 2015 | $701,000 | -23.5% | 405,091 | -16.4% | 0.00% | 0.0% |
Q1 2015 | $916,000 | -8.9% | 484,694 | -2.1% | 0.00% | 0.0% |
Q4 2014 | $1,006,000 | -24.9% | 495,319 | +44.5% | 0.00% | -50.0% |
Q3 2014 | $1,340,000 | -45.2% | 342,830 | -19.5% | 0.00% | -33.3% |
Q2 2014 | $2,447,000 | +28.0% | 425,706 | +22.5% | 0.00% | 0.0% |
Q1 2014 | $1,911,000 | +57.5% | 347,410 | +39.2% | 0.00% | +50.0% |
Q4 2013 | $1,213,000 | +98.2% | 249,498 | +11.0% | 0.00% | +100.0% |
Q3 2013 | $612,000 | +27.2% | 224,861 | +3.4% | 0.00% | 0.0% |
Q2 2013 | $481,000 | – | 217,534 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madison Street Partners, LLC | 1,707,764 | $9,819,643,000 | 9.95% |
SOPHROSYNE CAPITAL LLC | 951,362 | $5,472,000 | 5.57% |
GREAT POINT PARTNERS LLC | 1,694,256 | $9,742,000 | 4.33% |
INTREPID CAPITAL MANAGEMENT INC /DE/ | 436,148 | $2,508,000 | 2.19% |
AVALON CAPITAL MANAGEMENT | 110,837 | $637,000 | 0.53% |
Visium Asset Management, LP | 4,350,000 | $25,013,000 | 0.39% |
Cheyne Capital Management (UK) LLP | 25,000 | $144,000 | 0.17% |
Gruss Capital Management LP | 600,000 | $3,450,000 | 0.17% |
Capital Impact Advisors, LLC | 31,206 | $179,000 | 0.14% |
TFS CAPITAL LLC | 292,036 | $1,679,000 | 0.13% |